Radioactive Tracer Market Size, Scope, and Share by 2030
Radioactive Tracer Market: Size and Share
-
CAGR (2022 - 2030)17.8% -
Market Size 2022
US$ 14.68 Billion -
Market Size 2030
US$ 54.3 Billion
Market Dynamics
- Rising Prevalence of Chronic Diseases
- Increased Use of Nuclear Imaging Techniques
- Short Shelf-Life of Radioactive Tracers
- Availability of Substitutes to Nuclear Diagnosti Imaging Procedures
- Use of Radioactive Tracers in Cancer Diagnosis
Market Segmentation
- Technetium-99m & Tc-97m
- Iodine-131
- Iron-59
- Lutetium-171
- Rubidium Chloride & Ammonia
- Scandium-46
- Seaborgium-269
- Hassium-269
- Gallium Citrate Ga 67
- Prostate-Specific Membrane Antigen
- FDDNP & FDOPA
- Phosphorus-32 & Chromium-51
- Thallium-201
- F-18 FDG
- F-18 FAPI
- Ga-68 FAPI
- F-18 PSMA
- DOTATOC/DOTANOC/DOTATATE
- PET
- SPECT
- Oncology
- Pulmonary
- Neurology
- Cardiology
- Hospitals & Clinics
- Diagnostic Centers
- Academic & Research Institutes
Radioactive Tracer Market Players Density: Understanding Its Impact on Business Dynamics
The Radioactive Tracer Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Radioactive Tracer Market are:
- Rotem Industries Ltd
- Abx Advanced Biochemical Compounds Gmbh
- Invicro Llc
- Cardinal Health Inc
- Newcastle University
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Radioactive Tracer Market top key players overview